ReviewPathogens (Basel, Switzerland)2025
Resurgent Syphilis Across the Globe: A Public Health Perspective on Bridging Surveillance and Strategy.
Review in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Seroprevalence of Syphilis Among Pregnant Women on Antenatal Care Service at Wereda 04 Health Center in Kolfe Keraniyo Subcity, Addis Ababa, Ethiopia: A Cross-Sectional Study.Health science reports · 2026Article
- Review
- Neurosyphilis Presenting as Rapid Cognitive Decline With Demonstrated Improvement Posttreatment: A Case Report.Case reports in infectious diseases · 2026Article
- Case Report: Secondary syphilis with pulmonary involvement mimicking eosinophilic granulomatosis with polyangiitis - targeted next-generation sequencing as an adjunct in resolving an atypical non-exanthematous presentation.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Syphilis, a curable sexually transmitted infection, has resurged globally, challenging public health systems in both high-income countries and low- and middle-income countries (LMICs). In nations like the United States, the United Kingdom, parts of Europe, Canada, and Japan, cases have surged due to declining condom use, digital platforms facilitating casual sex, and practices like chemsex and broader drug use for sex, with rising congenital syphilis rates. In LMICs, such as those in East Africa, South Asia, Latin America, and Southeast Asia, limited healthcare access, inadequate prenatal screening, and socioeconomic barriers drive persistent high prevalence, particularly among pregnant women and vulnerable populations. Despite contextual differences, shared drivers include stigma, health disparities, and outdated surveillance systems. This resurgence underscores the need for globally coordinated, equity-focused strategies, including universal syphilis testing, modernized surveillance, and context-specific sexual health education. Addressing structural and behavioral factors through collaborative international efforts is critical to reversing this trend and strengthening global STI control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.